on VETOQUINOL (EPA:VETO)
Vetoquinol's Q1 2025 Financial Report Shows Mixed Results
Vetoquinol announced its first-quarter 2025 results, revealing sales of 85 million euros from Essential products, marking a slight growth of 1.8% at constant exchange rates. The company noted strong market performance in Europe with over 3% growth, the Americas (excluding the USA) with over 4%, and a robust 25% increase in the Asia-Pacific/Rest of the World regions. However, the USA market experienced a notable decline due to ongoing market uncertainties.
The group continued its rationalization of non-critical products, leading to a 2 million euro decline in these sales. Overall sales totaled 131 million euros in Q1 2025, slightly down from 134 million euros in the same quarter of 2024. Sales for companion animal products remained stable, while farm animal products saw a 7% decrease.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all VETOQUINOL news